Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Informational needs of patients with melanoma and their views on the utility of investigative tests
International Journal of Clinical Practice, 10/12/09
Constantinidou A et al. – The majority of participants wanted to know everything about their disease (88%). Prognostic information (> 85%) and information on palliative care input (97%) were highly valued. More than 50% expected the doctor to impart this information without negotiation. Nearly 70% of the responders who had previously had a PET scan felt they should decide if and when the scans should be performed. Fifty three percentage had undergone the sentinel node biopsy (SNB) because the doctor had suggested it. Patients with melanoma want detailed and prompt information about their disease including prognosis. Regular PET scans provide reassurance. The role of SNB is not clear to all patients.
Related Articles
Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09
Relevance Score: 97%
Slow-growing melanoma: a dermoscopy follow-up study
British Journal of Dermatology, 10/05/09
Relevance Score: 93%
Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09
Relevance Score: 91%
ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma
Journal of Investigative Dermatology, 11/03/09
Relevance Score: 91%
KIT as a Therapeutic Target in Melanoma
Journal of Investigative Dermatology, 10/23/09
Relevance Score: 90%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth
Clinical and Experimental Metastasis, 03/19/10
Melanoma MicroRNA Signature Predicts Post-Recurrence Survival
Clinical Cancer Research, 03/16/10
Increased melanoma risk in Parkinson disease: A prospective clinicopathological study
Archives of Neurology, 03/12/10
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


